Considering the positive results of the studies of probiotic on liver injury and there is no specific and effective drug for NAFLD treatment, the hepatoprotective effect of LBP involving NAFLD deserves further study. The gene discussed is LBP; the disease is metabolic dysfunction-associated steatotic liver disease.